Shares of Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) were up 3.7% during trading on Wednesday . The company traded as high as $3.45 and last traded at $3.32. Approximately 1,645,067 shares traded hands during mid-day trading, an increase of 238% from the average daily volume of 486,865 shares. The stock had previously closed at $3.20.
Windtree Therapeutics Stock Performance
The stock has a 50-day simple moving average of $6.96 and a 200 day simple moving average of $5.66. The company has a market cap of $1.85 million, a P/E ratio of -0.09 and a beta of 0.58.
Windtree Therapeutics (NASDAQ:WINT – Get Free Report) last announced its quarterly earnings data on Monday, August 19th. The company reported ($20.91) EPS for the quarter, missing analysts’ consensus estimates of ($8.11) by ($12.80). Sell-side analysts anticipate that Windtree Therapeutics, Inc. will post -2.38 earnings per share for the current fiscal year.
About Windtree Therapeutics
Windtree Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company's lead product is istaroxime which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock.
Featured Articles
- Five stocks we like better than Windtree Therapeutics
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is Short Interest? How to Use It
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- With Risk Tolerance, One Size Does Not Fit All
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
